Table I.
Baseline demographic information for overall study cohort Continuous variables are indicated with median (range)
| Age (yrs) | 64.7 (42.8–85.1) |
| Sex (% male) | 93.8% |
| Race (%) | |
| • White, not of Hispanic origin | 70% |
| • Black, not of Hispanic origin | 18.8% |
| • Hispanic | 11.3% |
| History of Smoking (%) | 91.3% |
| Currently Smoking (%) | 45.2% |
| Past Medical History | |
| • Hypertension (%) | 82.5% |
| • Hyperlipidemia (%) | 92.5% |
| • Coronary Artery Disease (%) | 21.3% |
| • Stroke (%) | 16.3% |
| • Diabetes (%) | 39.2% |
| Aspirin Dose (% on 325 mg) | 85% |
| Baseline Medications | |
| • Clopidogrel (% taking) | 26.3% |
| • Statin (% taking) | 97.5% |
| Body Mass Index (kg/m2) | 29.8 (18.0–53.8) |
| Systolic Blood Pressure (mm Hg) | 138 (92–199) |
| Diastolic Blood Pressure (mm Hg) | 74.5 (48–98) |
| Total Cholesterol (mg/dL) | 166 (106–337) |
| Triglycerides (mg/dL) | 140 (43–1986) |
| High-density lipoprotein cholesterol (mg/dL) | 40 (19–85) |
| Low-density lipoprotein cholesterol (mg/dL) | 92 (49–244) |
| hs-CRP (mg/L) | 2.96 (0.35–68.1) |